T1	intervention 10 56	topical microporous polysaccharide hemospheres
T2	condition 165 181	Seroma formation
T3	outcome-Measure 705 723	total drain output
T4	outcome-Measure 728 744	total drain days
T5	eligibility 802 867	patients undergoing mastectomy for the treatment of breast cancer
T6	control 929 964	no application in the control group
T7	No-of-participants 966 971	Fifty
T8	No-of-participants 1037 1046	Forty-two
T9	control-participants 1085 1087	21
T10	intervention-participants 1102 1104	21
T11	outcome 1396 1408	drain output
T12	outcome 1410 1434	Post hoc analyses of MPH
